HomeOwner SearchCategory Search
Visit USCOReceptor agonists and blockers products, applications, medical sales and new developments Philip Rotheim
Text Registration
Copyright Title
Receptor agonists and blockers products, applications, medical sales and new developments Philip Rotheim
Status
Published
on 14 Jun 2007
Year of Creation
1996
Copyright Claimant
Business Communications Company, Inc. (employer for hire)
Registration Number
TX0004455079
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0004455079) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Receptor agonists and blockers products, applications, medical sales and new developments Philip Rotheim" created in 1996. The copyright holder is Business Communications Company, Inc. (employer for hire), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Business Communications Company, Inc. (employer for hire).
Application Details
Registration Number
TX0004455079
Registration Date
6/14/2007
Year of Creation
1996
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Business Communications Company, Inc
Physical Description
255 p
Series Statement
Business opportunity report B-102
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.